[Correction of hyperlipidemia with Allicor]

Abstract

The hypocholesterolemic action of long-acting garlic powder tablets Allicor was investigated in a double-blind placebo-controlled study in men with mild hypercholesterolemia. Group 1 received allicor in a daily dose 600 mg, group 2 received placebo. The results show that allicor lowers total cholesterol, LDLP cholesterol, raises HDLP cholesterol and therefore can be recommended for correction of lipid content in patients with moderate hyperlipidemia.